Form 144 Filer Information UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 144

NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

Form 144

144: Issuer Information

Name of Issuer
Hims & Hers Health, Inc.
SEC File Number
001-38986
Address of Issuer
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Phone
1-213-830-6300
Name of Person for Whose Account the Securities are To Be Sold
Melissa Baird
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer
  1. Officer

144: Securities Information


RecordTitle of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
#1Class A Common
Goldman Sachs & Co. LLC
200 West Street
New York
NEW YORK
10282
12,966$153,647.10200,934,99705/08/2023
NYSE

144: Securities To Be Sold

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

RecordTitle of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
#1Class A Common02/06/2019Acquired as compensation -- Stock optionsThe Issuer12,96605/08/2023Compensation -- Cashless exercise / same-day sale


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

144: Securities Sold During The Past 3 Months

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

RecordName and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
#1Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common04/04/202311,299$114,436.27
#2Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common05/05/20239,899$119,692.77
#3Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common03/20/20239,333$89,058.29
#4Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common05/05/20239,133$109,441.65
#5Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common04/05/20238,033$78,621.38
#6Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common03/16/20238,100$78,327
#7Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common03/17/20239,976$97,611.17
#8Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common04/06/202310,233$101,162.41
#9Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common04/05/20231,600$16,080.48
#10Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common04/04/20239,133$91,424.98
#11Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common03/17/2023200$2,016.58
#12Melissa Baird
2269 Chestnut Street
Suite 523
San Francisco
CALIFORNIA
94123
Class A Common03/16/20233,843$38,938.04

144: Remarks and Signature

Remarks
The sales of shares set forth herein are made in connection with a selling plan dated 12/8/2022, that is intended to comply with Rule 10b5-1(c).
Date of Notice
05/08/2023
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
  1. 12/08/2022

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature
Goldman Sachs & Co. LLC on behalf of Melissa Baird

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Hims and Hers Health Charts.
Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Hims and Hers Health Charts.